Lyso-Gb3: A valid follow-up marker of treatment in male Fabry disease patients? by Walls, Susanne, Rainto, Miia, Kantola, Ilkka

Get full text

The Fabry PRO online tool for secure and continuous patient follow-up and communication by Walls, Susanne, Kantola, Ilkka, Rainto, Miia

Get full text

Does infusion time have effect on the efficacy of the enzyme by Walls, Susanne, Rainto, Miia, Kantola, Ilkka

Get full text

Improving home infusion follow-up by Walls, Susanne, Rainto, Miia, Kantola, Ilkka

Get full text

Delivering care to the patients: satisfaction among the Finnish Fabry disease patients by Walls, Susanne, Rainto, Miia, Isotalo, Anne, Kantola, Ilkka

Get full text

A new approch to follow-up of Finnish Fabry patients patient-based care by Walls, Susanne, Rainto, Miia, Niinikoski, Harri, Kantola, Ilkka

Get full text

PQ interval, QRS duration and QTc interval increased in Fabry disease patients treated by enzyme replacement therapy both for 10 and 15 years by Kantola, Ilkka, Annala, Antti-Pekka, Ekstrand, Agneta, Helio, Tiina, Hietaharju, Aki, Kantola, Taru, Kananen, Kristiina, Karhu, Anne, Kokkonen, Jorma, Kuusisto, Johanna, Pietila-Effati, Paivi, Rainto, Miia, Saarinen, Jukka, Sandini, Lorenzo, Taurio, Jyrki, Walls, Susanne, Valtola, Kati, Yliaska, Iina

Get full text

Deterioration in ECG parameters in Fabry females and males treated by enzyme replacement therapy either for 5 or 10 years by Kantola, Ilkka, Annala, Antti-Pekka, Ekstrand, Agneta, Helio, Tiina, Hietaharju, Aki, Kantola, Taru, Kananen, Kristiina, Karhu, Anne, Kokkonen, Jorma, Kuusisto, Johanna, Pietila-Effati, Paivi, Rainto, Miia, Saarinen, Jukka T., Sandini, Lorenzo, Ukkola, Olavi, Taurio, Jyrki, Tienari, Pentti, Walls, Susanne, Valtola, Kati

Get full text

Enzyme replacement therapy together with renin-angiotensin system inhibition seems to prevent kidney function decrease in most Finnish Fabry patients treated either for 5 or 10 yea... by Kantola, Ilkka, Annala, Antti-Pekka, Ekstrand, Agneta, Heliö, Tiina, Hietaharju, Aki, Kananen, Kristiina, Kantola, Taru, Karhu, Anne, Kokkonen, Jorma, Kuusisto, Johanna, Pietila-Effati, Päivi, Rainto, Miia, Saarinen, Jukka T., Sandini, Lorenzo, Savolainen, Markku, Taurio, Jyrki, Tienari, Pentti, Ukkola, Olavi, Valtola, Kati, Walls, Susanne, Yliaska, Iina

Get full text

PQ-interval and QRS duration increased in Fabry patients treated by enzyme replacement therapy for 12 years by Kantola, Ilkka, Annala, Antti-Pekka, Helio, Tiina, Hietaharju, Aki, Kantola, Taru, Kananen, Kristiina, Karhu, Anne, Kokkonen, Jorma, Kuusisto, Johanna, Pietila-Effati, Paivi, Rainto, Miia, Saarinen, Jukka, Sandini, Lorenzo, Savolainen, Markku, Taurio, Jyrki, Tienari, Pentti, Walls, Susanne, Valtola, Kati

Get full text

Enzyme replacement therapy carries for 4-7years in Fabry disease thereafter quality of life decreases by Kantola, I. Ilkka, Annala, Antti-Pekka, Helio, Tiina, Hietaharju, Aki, Kananen, Kristiina, Kantola, Taru, Karhu, Anne, Kuusisto, Johanna, Rainto, Miia, Saarinen, Jukka T., Sandini, Lorenzo, Savolainen, Markku, Taurio, Jyrki, Tienari, Pentti, Walls, Susanne, Valtola, Kati

Get full text

Enzyme replacement therapy carries for 4-7 years in Fabry disease thereafter quality of life decreases by Kantola, I. Ilkka, Annala, Antti-Pekka, Helio, Tiina, Hietaharju, Aki, Kananen, Kristiina, Kantola, Taru, Karhu, Anne, Kuusisto, Johanna, Rainto, Miia, Saarinen, Jukka T., Sandini, Lorenzo, Savolainen, Markku, Taurio, Jyrki, Tienari, Pentti, Walls, Susanne, Valtola, Kati

Get full text